CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 77 filers reported holding CUE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $69,384 | -64.2% | 14,218 | -17.1% | 0.00% | – |
| Q4 2021 | $194,000 | -24.5% | 17,147 | -2.8% | 0.00% | – |
| Q3 2021 | $257,000 | +18.4% | 17,646 | -5.4% | 0.00% | – |
| Q2 2021 | $217,000 | -6.9% | 18,661 | -2.5% | 0.00% | – |
| Q1 2021 | $233,000 | -2.9% | 19,131 | -0.3% | 0.00% | – |
| Q4 2020 | $240,000 | -4.0% | 19,195 | +15.5% | 0.00% | – |
| Q3 2020 | $250,000 | -35.6% | 16,626 | 0.0% | 0.00% | – |
| Q2 2020 | $388,000 | +103.1% | 16,626 | +23.4% | 0.00% | – |
| Q1 2020 | $191,000 | -10.7% | 13,476 | -0.3% | 0.00% | – |
| Q4 2019 | $214,000 | +65.9% | 13,511 | -7.1% | 0.00% | – |
| Q3 2019 | $129,000 | +8.4% | 14,549 | +9.5% | 0.00% | – |
| Q2 2019 | $119,000 | -33.5% | 13,287 | -12.3% | 0.00% | – |
| Q2 2018 | $179,000 | +67.3% | 15,154 | +97.6% | 0.00% | – |
| Q1 2018 | $107,000 | – | 7,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |